| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Gainers
Tempest Therapeutics, Inc. (NASDAQ:TPST) shares rose 279.8% to $0.9115 in pre-market trading, after the company announced it plans to report new and updated data from the global randomized combination study of TPST-1120 in first-line hepatocellular carcinoma in a premarket press release on Oct. 11.
Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares gained 211% to $2.77 in pre-market trading after falling 7% on Tuesday.
Athersys, Inc. (NASDAQ:ATHX) shares rose 20.7% to $0.14 in pre-market trading, after falling 60% on Tuesday. Athersys said it intends to conduct additional data analysis with independent statisticians because the sample size in the Phase 3 MASTERS-2 is insufficiently powered to achieve the primary endpoint.
Gaucho Group Holdings, Inc. (NASDAQ:VINO) shares climbed 42.7% to $1.27 in pre-market trading, after falling over 12% on Tuesday. Gaucho Group announced its journey towards organic cultivation for select sections of its renowned Pinot Noir and Cabernet Sauvignon vineyards.
Connexa Sports Technologies Inc. (NASDAQ:CNXA) rose 34.7% to $2.56 in pre-market trading.
AgileThought, Inc. (NASDAQ:AGIL) rose 27.7% to $0.1890 in pre-market trading. On Oct. 10, 2023, the Bankruptcy Court entered an order approving AgileThought Parties' and stalking horse buyer's entry into agreement.
Mangoceuticals, Inc. (NASDAQ:MGRX) shares jumped 24.3% to $0.7360 in pre-market trading after gaining 9% on Tuesday.
Elys Game Technology, Corp. (NASDAQ:ELYS) gained 19.6% to $0.5982 in pre-market trading. Elys Game Technology disclosed the expansion of its footprint in Washington, D.C. with the addition of a third sportsbook location, Grand Central Sportsbook on H Street.
Atreca, Inc. (NASDAQ:BCEL) shares surged 15.1% to $0.2417 in pre-market trading, after falling around 9% on Tuesday.
VOXX International Corp (NASDAQ:VOXX) shares rose 11.7% to $8.70 in pre-market trading as the company reported stronger-than-expected sales for its second quarter.
Losers
Silk Road Medical, Inc (NASDAQ:SILK) fell 38.5% to $8.61 in pre-market trading after the company announced preliminary third-quarter revenue results below estimates and issued FY23 revenue guidance below estimates.
SuperCom Ltd. (NASDAQ:SPCB) fell 25.1% to $0.6588 in pre-market trading, after surging 144% on Tuesday. SuperCom Ltd. is an Israel-based provider of digital identity and cybersecurity products and solutions to governments and private and public organizations throughout the world.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) shares fell 18.2% to $17.14 in pre-market trading.
Mobilicom Limited (NASDAQ:MOB) shares fell 17.1% to $1.70 in pre-market trading, after jumping over 44% on Tuesday. The Bank of New York Mellon reported in a filing late Monday that it increased its stake in the company.
SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 16.7% to $2.39 in pre-market trading. SMX shares jumped 69% on Tuesday after the company announced it secured a majority stake in True Gold Consortium.
DaVita Inc. (NYSE:DVA) fell 16.5% to $76.23 in pre-market. Rockwell Medical said on Sept. 18, that the company and Davita entered into an amended and restated products purchase agreement.
E2open Parent Holdings, Inc. (NYSE:ETWO) fell 15.3% to $3.72 in pre-market trading as the company posted downbeat results for its second quarter and named Andrew Appel as interim CEO, effective immediately.
ParaZero Technologies Ltd. (NASDAQ:PRZO) shares fell 7.4% to $2.25 in pre-market trading after declining 10% on Tuesday. ParaZero Technologies recently announced an Australian regulator approved the first commercial drone flights in populated areas and near people using ParaZero safety systems.
Hyliion Holdings Corp. (NYSE:HYLN) shares fell 14.2% to $1.02 in pre-market trading after the company announced a strategic review of alternatives for Electric Powertrain Business.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shares fell 11.9% to $2.66 in pre-market trading.
Now Read This: Fastenal Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Posted In: AGIL ATHX BCEL CASI CNXA DVA ELYS ETWO FMS HYLN MGRX MOB PRZO SILK SMX SPCB TPST VINO VOXX WHLR
